Skin Irritation Test of LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects

Trial Profile

Skin Irritation Test of LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Paraffin
  • Indications Plaque psoriasis; Psoriasis
  • Focus Therapeutic Use
  • Sponsors LEO Pharma
  • Most Recent Events

    • 21 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 09 Mar 2015 New trial record
    • 08 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top